Dow Down 0.11% Nasdaq Up 0.21%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
50.88 Down 0.87(1.68%) 2:15PM EDT - Nasdaq Real Time Price
Prev Close:51.75
Open:51.75
Bid:51.20 x 100
Ask:51.29 x 100
1y Target Est:84.80
Beta:0.95
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:50.88 - 52.22
52wk Range:39.75 - 80.42
Volume:190,398
Avg Vol (3m):381,741
Market Cap:1.06B
P/E (ttm):87.27
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDDown 1.68%1.06B
LLYUp 0.60%66.87B
MRKUp 0.59%170.77B
RHHBYDown 0.11%247.33B

Key Statistics

Forward P/E (1 yr):21.07
P/S (ttm):19.80
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.55
Quarterly EPS Est (Sep-14) :0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback